HLA-DQ molecules as affinity matrix for identification of gluten T cell epitopes

Journal of Immunology

Volumn 193, Issue 9, 2014, Pages 4497-4506

  Dørum, Siri ^a,b   Bodd, Michael ^b   Fallang, Lars Egil ^a   Bergseng, Elin ^a   Christophersen, Asbjørn ^a   Johannesen, Marie K ^a   Qiao, Shuo Wang ^a   Stamnaes, Jorunn ^a   De Souza, Gustavo A ^a,b   Sollid, Ludvig M ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLUTEN; HLA ANTIGEN CLASS 2; HLA DQ2.2 ANTIGEN; HLA DQ2.5 ANTIGEN; UNCLASSIFIED DRUG; GLIADIN; HLA DQ ANTIGEN; PEPTIDE; PROTEIN BINDING;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CELIAC DISEASE; CONTROLLED STUDY; FEASIBILITY STUDY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NONHUMAN; T LYMPHOCYTE; TRITICUM AESTIVUM; CELL LINE; CHEMISTRY; EPITOPE MAPPING; GEL CHROMATOGRAPHY; IMMUNOLOGY; PROCEDURES; WHEAT;

AMINO ACID SEQUENCE; CELIAC DISEASE; CELL LINE; CHROMATOGRAPHY, GEL; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; GLIADIN; GLUTENS; HLA-DQ ANTIGENS; HUMANS; PEPTIDES; PROTEIN BINDING; T-LYMPHOCYTES; TRITICUM;

EID: 84908131708     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301466     Document Type: Article

References (38)

1. Nepom, G. T. 1995. Class II antigens and disease susceptibility. Annu. Rev. Med. 46: 17-25.
2. Jones, E. Y., L. Fugger, J. L. Strominger, and C. Siebold. 2006. MHC class II proteins and disease: a structural perspective. Nat. Rev. Immunol. 6: 271-282.
3. Thorsby, E. 1997. Invited anniversary review: HLA associated diseases. Hum. Immunol. 53: 1-11.
4. Meresse, B., G. Malamut, and N. Cerf-Bensussan. 2012. Celiac disease: an immunological jigsaw. Immunity 36: 907-919.
5. Sollid, L. M. 2002. Coeliac disease: dissecting a complex inflammatory disorder. Nat. Rev. Immunol. 2: 647-655.
6. Lettre, G., and J. D. Rioux. 2008. Autoimmune diseases: insights from genome-wide association studies. Hum. Mol. Genet. 17(R2): R116-R121.
7. Bodd, M., C. Y. Kim, K. E. Lundin, and L. M. Sollid. 2012. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease. Gastroenterology 142: 552-561.
8. ∗0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J. Exp. Med. 178: 187-196.
9. Wieser, H. 2007. Chemistry of gluten proteins. Food Microbiol. 24: 115-119.
10. ∗02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum. Immunol. 64: 469-477.
11. Sollid, L. M., and B. A. Lie. 2005. Celiac disease genetics: current concepts and practical applications. Clin. Gastroenterol. Hepatol. 3: 843-851.
12. Sollid, L. M., S. W. Qiao, R. P. Anderson, C. Gianfrani, and F. Koning. 2012. Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics 64: 455-460.
13. Molberg, O., S. N. Mcadam, R. Körner, H. Quarsten, C. Kristiansen, L. Madsen, L. Fugger, H. Scott, O. Norén, P. Roepstorff, et al. 1998. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med. 4: 713-717.
14. van de Wal, Y., Y. Kooy, P. van Veelen, S. Peña, L. Mearin, G. Papadopoulos, and F. Koning. 1998. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J. Immunol. 161: 1585-1588.
15. Arentz-Hansen, H., R. Körner, O. Molberg, H. Quarsten, W. Vader, Y. M. Kooy, K. E. Lundin, F. Koning, P. Roepstorff, L. M. Sollid, and S. N. McAdam. 2000. The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J. Exp. Med. 191: 603-612.
16. Fallang, L. E., E. Bergseng, K. Hotta, A. Berg-Larsen, C. Y. Kim, and L. M. Sollid. 2009. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nat. Immunol. 10: 1096-1101.
17. Quarsten, H., O. Molberg, L. Fugger, S. N. McAdam, and L. M. Sollid. 1999. HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope. Eur. J. Immunol. 29: 2506-2514.
18. Piper, J. L., G. M. Gray, and C. Khosla. 2002. High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue. Biochemistry 41: 386-393.
19. Stamnaes, J., B. Fleckenstein, and L. M. Sollid. 2008. The propensity for de-amidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions. Biochim. Biophys. Acta 1784: 1804-1811.
20. Quarsten, H., S. N. McAdam, T. Jensen, H. Arentz-Hansen, Ø. Molberg, K. E. Lundin, and L. M. Sollid. 2001. Staining of celiac disease-relevant T cells by peptide-DQ2 multimers. J. Immunol. 167: 4861-4868.
21. Stadinski, B. D., L. Zhang, F. Crawford, P. Marrack, G. S. Eisenbarth, and J. W. Kappler. 2010. Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register. Proc. Natl. Acad. Sci. USA 107: 10978-10983.
22. Sloan, V. S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D. M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375: 802-806.
23. Kelstrup, C. D., C. Young, R. Lavallee, M. L. Nielsen, and J. V. Olsen. 2012. Optimized fast and sensitive acquisition methods for shotgun proteomics on a quadrupole orbitrap mass spectrometer. J. Proteome Res. 11: 3487-3497.
24. Vader, W., D. Stepniak, Y. Kooy, L. Mearin, A. Thompson, J. J. van Rood, L. Spaenij, and F. Koning. 2003. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc. Natl. Acad. Sci. USA 100: 12390-12395.
25. Bodd, M., S. Tollefsen, E. Bergseng, K. E. Lundin, and L. M. Sollid. 2012. Evidence that HLA-DQ9 confers risk to celiac disease by presence of DQ9-restricted gluten-specific T cells. Hum. Immunol. 73: 376-381.
26. Molberg, O., S. N. McAdam, K. E. Lundin, and L. M. Sollid. 2000. Studies of gliadin-specific T-cells in celiac disease. Methods Mol. Med. 41: 105-124.
27. + T cells in blood as potential diagnostic marker for coeliac disease without oral gluten challenge. United European Gastroenterol. J. 2: 268-278.
28. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II ab dimers and facilitates peptide loading. Cell 82: 155-165.
29. Shan, L., Ø. Molberg, I. Parrot, F. Hausch, F. Filiz, G. M. Gray, L. M. Sollid, and C. Khosla. 2002. Structural basis for gluten intolerance in celiac sprue. Science 297: 2275-2279.
30. Arentz-Hansen, E. H., S. N. McAdam, O. Molberg, C. Kristiansen, and L. M. Sollid. 2000. Production of a panel of recombinant gliadins for the characterisation of T cell reactivity in coeliac disease. Gut 46: 46-51.
31. Sollid, L. M., and B. Jabri. 2005. Is celiac disease an autoimmune disorder? Curr. Opin. Immunol. 17: 595-600.
32. Dørum, S., M. O. Arntzen, S. W. Qiao, A. Holm, C. J. Koehler, B. Thiede, L. M. Sollid, and B. Fleckenstein. 2010. The preferred substrates for trans-glutaminase 2 in a complex wheat gluten digest are peptide fragments harboring celiac disease T-cell epitopes. PLoS ONE 5: e14056.
33. Hartman, I. Z., A. Kim, R. J. Cotter, K. Walter, S. K. Dalai, T. Boronina, W. Griffith, D. E. Lanar, R. Schwenk, U. Krzych, et al. 2010. A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes. Nat. Med. 16: 1333-1340.
34. Fallang, L. E., S. Roh, A. Holm, E. Bergseng, T. Yoon, B. Fleckenstein, A. Bandyopadhyay, E. D. Mellins, and L. M. Sollid. 2008. Complexes of two cohorts of CLIP peptides and HLA-DQ2 of the autoimmune DR3-DQ2 haplo-type are poor substrates for HLA-DM. J. Immunol. 181: 5451-5461.
35. van de Wal, Y., Y. M. Kooy, P. van Veelen, W. Vader, S. A. August, J. W. Drijfhout, S. A. Peña, and F. Koning. 1999. Glutenin is involved in the gluten-driven mucosal T cell response. Eur. J. Immunol. 29: 3133-3139.
36. Shan, L., S. W. Qiao, H. Arentz-Hansen, Ø. Molberg, G. M. Gray, L. M. Sollid, and C. Khosla. 2005. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue. J. Proteome Res. 4: 1732-1741.
37. Anderson, R. P., and B. Jabri. 2013. Vaccine against autoimmune disease: antigen-specific immunotherapy. Curr. Opin. Immunol. 25: 410-417.
38. Vader, L. W., A. de Ru, Y. van der Wal, Y. M. Kooy, W. Benckhuijsen, M. L. Mearin, J. W. Drijfhout, P. van Veelen, and F. Koning. 2002. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J. Exp. Med. 195: 643-649.